Blenrep
belantamab mafodotin
Listed by GlaxoSmithKline LLC
- Strength
- 50 mg/mL
- Form
- Injection, Powder, For Solution
- Route
- Intravenous
What it contains
- Belantamab Mafodotin 50 mg/mL
FDA record
| Dosage form | Injection, Powder, For Solution |
|---|---|
| Route | Intravenous |
| Approval route | BLA — biologic licence |
| NDC code | 0173-0913 |
| FDA application | BLA761440 |
| RxNorm concept | 2725585 |
| Package sizes listed | 1 |
| Marketed since | October 2025 |
Information only, not medical advice. Nothing on this page indicates that a medication is safe or suitable for you. Speak to a prescriber or pharmacist before starting, stopping or switching any medicine.